• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2006 Fiscal Year Final Research Report Summary

Exhaustive analysis about juvenile idiopathic arthritis by using an anti-IL-6 receptor antibody

Research Project

Project/Area Number 16390305
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionYokohama City University

Principal Investigator

YOKOTA Shumpei  Yokohama City University, Medical Research, Professor, 医学研究科, 教授 (10158363)

Co-Investigator(Kenkyū-buntansha) MORI Masaaki  Yokohama City University, Medical Department, Associate professor, 医学部, 準教授 (30254204)
MITSUDA Toshihiro  Yokohama City University, Medical Hospital, Associate professor, 付属病院, 準教授 (20336548)
NARUTO Takuya  Yokohama City University, Medical Department, Researcher, 医学部, 研究員 (60438124)
Project Period (FY) 2004 – 2006
Keywordsjuvenile idiopathic arthritis / IL-6 / anti IL-6 receptor antibody / investigation for pathogenesis / hypercytokine diseases
Research Abstract

We analyzed the identification of the target molecule of the IL-6 obstruction treatment by using proteomics method such as 2D-DIGE (fluorescent labeling 2 dimension differential gel electrophoresis) and iTRAQ (Isotope Tag for Relative and Absolute Quantitation) method. Additionally, we examined the role of IL-6 on Kawasaki disease or CINCA syndrome as an axis of this research.
Furthermore, we would like to analyze the IL-6 diseases (cytokine-related disease) in pediatric field, and to examine the structure and/or the function of the obstruction target molecule of antiIL-6 receptor antibody treatment front and back in detail in future. Finally, in this study, we detected lots of proteins in sera and plasma of JIA patients using two methods, 2D-DIGE and iTRAQ and could identify some of them.

  • Research Products

    (3 results)

All Other

All Journal Article (3 results)

  • [Journal Article] Tocilizumab, Anti-IL-6 Receptor Monoclonal Antibody : Randomized, Double-blind, Placebo-controlled, Withdrawal Phase III Trial of Efficacy and Safety against Systemic-onset Juvenile Idiopathic Arthritis

    • Author(s)
      Yokota S, Imagawa T.
    • Journal Title

      NEJM (in print)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Proposal for Juvenile Idiopathic Arthritis Guidance on Diagnosis and Treatment in Primary Care (2007)

    • Author(s)
      Yokota S, Mori M.
    • Journal Title

      Modern Rheumatology (in print)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Scientific Study on the Occurrence Status of Influenza-associated Symptoms

    • Author(s)
      Yokota S, Mori M
    • Journal Title

      JAMA (under construction)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2008-05-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi